1,069 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Kesler Norman & Wride LLC

Kesler Norman & Wride LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,069 shares of the medical equipment provider's stock, valued at approximately $558,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC raised its position in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after purchasing an additional 92 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after buying an additional 9,194 shares during the period. Benjamin Edwards Inc. lifted its stake in shares of Intuitive Surgical by 148.7% during the 3rd quarter. Benjamin Edwards Inc. now owns 13,673 shares of the medical equipment provider's stock worth $6,718,000 after acquiring an additional 8,176 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Janus Henderson Group PLC now owns 689,939 shares of the medical equipment provider's stock valued at $338,948,000 after acquiring an additional 9,727 shares during the period. Finally, Integrated Wealth Concepts LLC grew its position in Intuitive Surgical by 1.9% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 4,821 shares of the medical equipment provider's stock valued at $2,369,000 after acquiring an additional 90 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Finally, Robert W. Baird reduced their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, March 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Stock Down 8.7 %

ISRG traded down $43.03 on Friday, reaching $451.58. The company had a trading volume of 4,106,917 shares, compared to its average volume of 1,542,647. The stock has a 50-day moving average price of $545.18 and a 200-day moving average price of $532.30. The stock has a market capitalization of $160.84 billion, a PE ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.